NEW YORK – Hims & Hers Health, Inc. (NYSE: HIMS) shares experienced a notable surge in morning trading, climbing over 3% as the market opened. The telehealth and wellness platform’s stock reached $58.27, an increase of $1.74 per share, reflecting positive investor sentiment.
As of 10:24:34 AM EDT, Hims & Hers (HIMS) was actively trading, building on an opening price of $56.93, which was already above its previous close of $56.53. The day has seen the stock fluctuate within a range of $55.91 to $58.77. This upward momentum places the current price comfortably within its 52-week range of $13.47 to $72.98, showcasing significant growth over the past year.
Market activity for HIMS was robust, with a volume of 11,764,843 shares traded by mid-morning. While this is below its average volume of 35,219,219, the significant price movement indicates strong buying interest. The company currently holds an intraday market capitalization of approximately $12.989 billion.
From a valuation perspective, Hims & Hers Health, Inc. has a Price-to-Earnings (P/E) ratio (TTM) of 85.34, with an Earnings Per Share (EPS) (TTM) of $0.68. The stock’s Beta (5Y Monthly) is 2.10, suggesting it is more volatile than the overall market.
Interestingly, while the stock is performing well today, the 1-year target estimate for HIMS is $47.56. The company does not currently offer a forward dividend. Investors will be looking ahead to the next earnings date, projected for August 4, 2025.
The rise in Hims & Hers’ stock price comes at a time when the broader telehealth and digital health sectors continue to evolve. Investors are closely watching companies like HIMS for innovation and expansion in accessible healthcare solutions. The on-screen prompt “Time to buy HIMS?” further underscores the current focus on the company’s stock performance.
Frequently Asked Questions (FAQ) about Hims & Hers Health, Inc. (HIMS) Stock:
Q1: What is Hims & Hers Health, Inc.?
A: Hims & Hers Health, Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to sexual health, hair loss, dermatology, mental health, and primary care.
Q2: What is the stock ticker for Hims & Hers Health, Inc.?
A: The stock ticker for Hims & Hers Health, Inc. is HIMS, and it trades on the New York Stock Exchange (NYSE).
Q3: What was the HIMS stock price movement highlighted in the recent data?
A: As of 10:24:34 AM EDT on the day of the image, HIMS stock was trading at $58.27, which was an increase of $1.74 or +3.08% for the day.
Q4: What is the day’s trading range for HIMS stock?
A: Based on the provided image, the day’s trading range for HIMS stock was $55.91 – $58.77.
Q5: What is the 52-week range for HIMS stock?
A: The 52-week range for Hims & Hers (HIMS) stock is $13.47 – $72.98.
Q6: What is the market capitalization of Hims & Hers?
A: The intraday market capitalization for Hims & Hers was approximately $12.989 billion.
Q7: Does HIMS stock pay a dividend?
A: No, according to the information provided, Hims & Hers Health, Inc. (HIMS) does not currently pay a dividend.
Q8: What is the P/E ratio for HIMS?
A: The Price-to-Earnings (P/E) ratio (TTM) for HIMS was 85.34.
Q9: What is the analyst 1-year target estimate for HIMS stock?
A: The 1-year target estimate for HIMS stock is $47.56.
Q10: Is HIMS considered a volatile stock?
A: With a Beta (5Y Monthly) of 2.10, HIMS stock is considered more volatile than the overall market (a beta greater than 1 indicates higher volatility).
Q11: When is the next Hims & Hers earnings date?
A: The next projected earnings date for Hims & Hers is August 4, 2025.
Disclaimer: This article is for informational purposes only and should not be considered financial advice. Stock market investments are subject to risk, and investors should conduct their own due diligence or consult with a financial advisor before making investment decisions.
